financetom
Business
financetom
/
Business
/
Waste Management Q3 Adjusted Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Waste Management Q3 Adjusted Earnings, Revenue Rise
Nov 3, 2024 1:12 PM

05:30 PM EDT, 10/28/2024 (MT Newswires) -- Waste Management (WM) reported Q3 adjusted earnings late Monday of $1.96 per diluted share, up from $1.63 a year earlier.

Analysts polled by Capital IQ expected $1.88.

Revenue in the quarter ended Sept. 30 rose to $5.61 billion from $5.20 billion a year earlier. Analysts surveyed by Capital IQ expected $5.51 billion.

Price: 210.26, Change: +2.00, Percent Change: +0.96

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alnylam Pharmaceuticals Insider Sold Shares Worth $632,759, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $632,759, According to a Recent SEC Filing
Aug 20, 2025
05:36 PM EDT, 08/19/2025 (MT Newswires) -- Kevin Joseph Fitzgerald, Chief Scientific Officer, Executive Vice President, and Head of Research, on August 15, 2025, sold 1,396 shares in Alnylam Pharmaceuticals ( ALNY ) for $632,759. Following the Form 4 filing with the SEC, Fitzgerald has control over a total of 23,256 common shares of the company, with 22,719 shares held...
Legalzoom.com Insider Sold Shares Worth $272,166, According to a Recent SEC Filing
Legalzoom.com Insider Sold Shares Worth $272,166, According to a Recent SEC Filing
Aug 20, 2025
05:37 PM EDT, 08/19/2025 (MT Newswires) -- Nicole Miller, Chief Legal Officer, on August 15, 2025, sold 25,154 shares in Legalzoom.com ( LZ ) for $272,166. Following the Form 4 filing with the SEC, Miller has control over a total of 960,032 common shares of the company, with 960,032 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1286139/000128613925000093/xslF345X05/wk-form4_1755639276.xml ...
Alnylam Pharmaceuticals Insider Sold Shares Worth $3,163,346, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $3,163,346, According to a Recent SEC Filing
Aug 20, 2025
05:34 PM EDT, 08/19/2025 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on August 15, 2025, sold 6,979 shares in Alnylam Pharmaceuticals ( ALNY ) for $3,163,346. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 56,628 common shares of the company, with 56,221 shares held directly and 407 controlled indirectly. SEC Filing:...
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,030,727, According to a Recent SEC Filing
Alnylam Pharmaceuticals Insider Sold Shares Worth $1,030,727, According to a Recent SEC Filing
Aug 20, 2025
05:34 PM EDT, 08/19/2025 (MT Newswires) -- Jeffrey V. Poulton, Executive Vice President, Chief Financial Officer, on August 15, 2025, sold 2,274 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,030,727. Following the Form 4 filing with the SEC, Poulton has control over a total of 50,178 common shares of the company, with 50,121 shares held directly and 57 controlled...
Copyright 2023-2026 - www.financetom.com All Rights Reserved